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Introduction
Mitochondria are essential organelles of eukaryotic cells that 
participate in several metabolic pathways, cell signaling, and 
apoptosis (Saraste, 1999; Suen et al., 2008; Szabadkai and 
Duchen, 2008). Mitochondria have a very plastic morphology 
and constantly fuse and divide. Genetic studies in Drosophila 
melanogaster and Saccharomyces cerevisiae have led to the 
identification  of  components  of  the  enzymatic  machineries 
that bring about mitochondrial fusion and fission (Okamoto 
and Shaw, 2005; Berman et al., 2008; Lackner and Nunnari, 
2008; Westermann, 2008; Hoppins and Nunnari, 2009). Im-
portant components of these machineries are members of the 
family of dynamin-related GTPases (Praefcke and McMahon, 
2004).  It  has  been  established  that  an  inner  mitochondrial 
membrane (IMM)– and outer mitochondrial membrane (OMM)–
specific machinery acts during mitochondrial fusion. Specifically, 
the dynamin-related GTPases Fzo1/Mfn1,2 are required for 
OMM fusion (Hermann et al., 1998; Chen et al., 2003). Conversely, 
the dynamin-related GTPases Mgm1/Opa1 are required for 
IMM  fusion  (Sesaki  et  al.,  2003;  Misaka  et  al.,  2006).   
Recent studies have demonstrated that the role of these pro-
teins  is  conserved  in  Caenorhabditis  elegans.  Specifically,   
the Fzo1/Mfn1,2 homologue, FZO-1, and the Mgm1/Opa1 
homologue, EAT-3, are required for mitochondrial fusion in 
C. elegans (Breckenridge et al., 2008; Ichishita et al., 2008; 
Kanazawa et al., 2008; Tan et al., 2008). EAT-3/Mgm1/Opa1 
also plays a role in mitochondrial cristae structure mainte-
nance (Frezza et al., 2006; Meeusen et al., 2006; Kanazawa   
et al., 2008). In addition, C. elegans EAT-3 has been shown to 
be required for resistance to oxidative stress caused by free 
radicals (Kanazawa et al., 2008).
The molecular mechanisms underlying mitochondrial fu-
sion are still unclear. However, with the development of in vitro 
and in vivo mitochondrial fusion assays, these mechanisms are 
now being elucidated. Mitochondrial fusion seems to involve 
four distinct steps: (1) OMM tethering, (2) OMM fusion, (3) IMM 
tethering, and (4) IMM fusion (Hoppins and Nunnari, 2009). In 
addition, GTP binding and hydrolysis is required for mitochon-
drial fusion (Meeusen et al., 2004). IMM potential is also important 
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phosphatases Mfn1,2 and Opa1 are required for 
mitochondrial fusion. However, how their activi-
ties are controlled and coordinated is largely unknown. 
We present data that implicate the BCL-2–like protein 
CED-9 in the control of mitochondrial fusion in Cae-
norhabditis elegans. We demonstrate that CED-9 can 
promote  complete  mitochondrial  fusion  of  both  the 
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show that this fusion is dependent on the C. elegans 
Mfn1,2 homologue FZO-1 and the C. elegans Opa1 
homologue EAT-3. Furthermore, we show that CED-9 
physically  interacts  with  FZO-1  in  vivo  and  that  the 
ability of CED-9 to interact with FZO-1 is important for 
its  ability  to  cause  mitochondrial  fusion.  CED-9– 
induced  mitochondrial  fusion  is  not  required  for  the 
maintenance of mitochondrial morphology during em-
bryogenesis or in muscle cells, at least under normal 
conditions and in the absence of stress. Therefore, we 
propose  that  the  BCL-2–like  CED-9  acts  through   
FZO-1/Mfn1,2 and EAT-3/Opa1 to promote mitochon-
drial fusion in response to specific cellular signals.
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one or two highly globular mitochondria per cell (90%, n = 8, 
three independent transgenic lines; Fig. 1 B, row 2). A similar 
phenotype was observed in embryos expressing mitogfp and 
ced-9(n1950gf) (81%, n = 22, three independent transgenic lines; 
Fig. S1 B, row 2), indicating that this mutation, which enhances 
the ability of CED-9 to block apoptosis (Hengartner and Horvitz, 
1994a), does not compromise the ability of CED-9 to promote 
mitochondrial fusion. In both cases, 3D reconstruction of z stacks 
confirmed the presence of one or two highly globular organelles 
per cell (Table S1 and Videos 1, 2, and 5).
Unfortunately, the relatively small size of embryonic cells 
(5 µm) prevented us from analyzing the ultrastructure of these 
highly globular organelles. Therefore, we expressed ced-9(wt) 
in  body  wall  muscle  cells  and  analyzed  mitochondrial  mor-
phology in these cells in larvae of the fourth larval stage (L4 
larvae; at this stage of development, body wall muscle cells are   
60-µm long and 8-µm wide). However, we failed to obtain 
stable transgenic lines expressing ced-9(wt) under the control 
of  a  body  wall  muscle–specific  promoter  (Pmyo-3),  suggesting 
that the constitutive overexpression of ced-9(wt) in these cells 
might  be  toxic.  For  this  reason,  we  conditionally  expressed 
ced-9(wt) in body wall muscle cells using the Smg-inducible 
system (Pulak and Anderson, 1993). Body wall muscle cells of 
animals expressing mitogfp alone have tubular mitochondria 
(100%, n = 6, one line; Fig. 2 B, row 1). This result is consis-
tent  with  previous  studies  (Ichishita  et  al.,  2008;  Kanazawa   
et al., 2008; Tan et al., 2008) and with the mitochondrial mor-
phology we observed in wild-type embryos (Fig. 1). In contrast,   
after the induction of transgene expression, animals carrying a   
Pmyo-3  ced-9(wt)  (3untranslated  region  [UTR]smg)  transgene 
have highly globular mitochondria (50%, n = 8, three independent 
lines; Fig. 2 B, row 2, arrows). This phenotype is reminiscent of 
the phenotype observed in embryos (Fig. 1) and is consistent with 
previous experiments (Tan et al., 2008). In some cells, we also 
noticed clusters of mitochondria (Fig. 2 B, row 3, arrowhead). 
These clusters, which are very similar to the aggregates induced 
by fzo-1 overexpression (57%, n = 7, one line; Fig. 2 B, row 5, 
arrowheads), could represent fusion intermediates.
Analysis by EM of cross sections of wild-type body wall 
muscle cells of L4 larvae revealed mainly small and round 
mitochondria lying in the muscle belly just below the sarco-
mere. (12/12 muscle cells, four animals; Fig. 3 A). In contrast, 
we found that in a given cross section, ced-9(wt) overexpres-
sion can induce the formation of one large mitochondrion 
per cell (2/18 muscle cells, three animals; Fig. 3 B), whereas 
fzo-1 overexpression only induced the formation of clusters 
of mitochondria (3/14 muscle cells, three animals; Fig. 3 E). 
These phenotypes and their respective frequencies of occur-
rence are consistent with what we observed by fluorescent 
microscopy (Fig. 2). We estimate that 25% of the muscle 
cells are mitoGFP positive and therefore express the trans-
gene. Because 50% and 57% of the mitoGFP-positive muscle 
cells show a phenotype after ced-9(wt) or fzo-1 overexpres-
sion, respectively (see previous paragraph), we expected to 
see alterations in mitochondrial morphology by EM in 12.5% 
and  14.5%  of  the  cells,  respectively.  Using  morphometric 
analysis, we confirmed that a subpopulation of mitochondria 
for mitochondrial fusion; however, its mechanistic role in the 
fusion process remains elusive (Meeusen et al., 2004). The fu-
sion of the OMM and IMM are temporally linked in vivo, indi-
cating the existence of mechanisms to coordinate the OMM and 
IMM fusion machineries. It has been proposed that the S. cere-
visiae protein Ugo1, which interacts with both Fzo1 and Mgm1, 
mediates the coordination of these two events (Sesaki and Jensen, 
2004; Hoppins et al., 2009). To date, no structural or functional 
homologue of Ugo1 has been characterized in higher eukaryotes. 
Thus, how IMM and OMM fusion are coordinated in higher eu-
karyotes remains to be elucidated.
The mechanisms underlying the regulation of dynamin-
related GTPases are starting to be elucidated (Cerveny et al., 
2007). The activity of S. cerevisiae Fzo1 is in part controlled by 
protein degradation (Fritz et al., 2003; Neutzner and Youle, 2005), 
and mammalian Opa1 and yeast Mgm1 can be regulated through 
the generation of different isoforms and by proteolysis (Herlan 
et al., 2004; Cipolat et al., 2006; Ishihara et al., 2006). Recently, 
BCL-2–like proteins, which play critical roles during apoptosis 
(Youle and Strasser, 2008), have also been implicated in the 
control of mitochondrial morphology and have been proposed 
to do so by regulating the activity of dynamin-related GTPases 
(Jagasia et al., 2005; Delivani et al., 2006; Karbowski et al., 2006; 
Brooks et al., 2007; Li et al., 2008; Tan et al., 2008; Berman   
et al., 2009). All of these regulatory mechanisms are thought to 
induce appropriate mitochondrial morphology changes in re-
sponse to certain cellular signals or events such as cell division 
(Cerveny et al., 2007).
In this study, we demonstrate that the BCL-2–like protein 
CED-9 of C. elegans can induce complete mitochondrial fusion 
in a manner that is dependent on the ability of CED-9 to physi-
cally interact with the dynamin-related GTPase FZO-1, the   
C. elegans orthologue of Fzo1/Mfn1,2. We propose that CED-9 
acts to control and coordinate the fusion of the OMM and IMM 
in healthy cells in response to specific cellular signals.
Results
CED-9 can promote complete mitochondrial 
fusion in C. elegans
It has been reported that the expression of the C. elegans ced-9 
gene (ced-9(wt)) in cultured mammalian cells can promote mi-
tochondrial fusion (Delivani et al., 2006). To determine whether 
the expression of ced-9(wt) can also promote mitochondrial fu-
sion in C. elegans, we analyzed the effect of ced-9(wt) expres-
sion on mitochondrial morphology in C. elegans embryos. To 
that end, we used transgenic lines expressing mitogfp and ced-
9(wt) under the control of an inducible promoter and analyzed 
mitochondrial morphology in transgenic embryos during mid-
gastrulation (150 min after the first cell division; we estimate 
that the level of CED-9 protein in transgenic embryos is about 
five times higher than the endogenous level). Similar to what we 
observed in wild-type embryos stained with tetramethyl rho-
damine ethyl ester (TMRE; see Fig. 4 B, row 1), embryos ex-
pressing mitogfp alone had tubular mitochondria (82%, n = 14, 
four independent transgenic lines; Fig. 1 B, row 1). In contrast, 
the majority of embryos expressing mitogfp and ced-9(wt) had 527 ROLE OF CED-9/BCL-2 IN MITOCHONDRIAL FUSION • Rolland et al.
clusters,  which  might  constitute  fusion  intermediates  (2/18 
muscle cells, three animals; Fig. 3 C). Finally, in one case, we 
also observed mitochondria composed of multiple concentric 
layers as described previously by Tan et al. (2008; 1/18 muscle 
cells, three animals; Fig. 3 D). This phenotype could be caused 
of  ced-9(wt)–overexpressing  animals  have  increased  thick-
ness (unpublished data). Interestingly, despite their abnormal 
size, CED-9–induced large mitochondria in general seem to 
have  normal  OMM,  IMM,  and  cristae  structures.  In  some 
cells overexpressing ced-9(wt), we observed mitochondrial   
Figure 1.  CED-9 promotes FZO-1– and EAT-3–dependent mitochondrial fusion. (A) Schematic of the mitochondrial morphologies observed in embryos. 
(B) Wild-type (+/+), fzo-1(tm1133), or eat-3(ad426) transgenic lines expressing mitogfp alone (PHSmitogfp) or in the presence of ced-9(wt) (PHSmitogfp + 
PHSced-9(wt)) were analyzed by Nomarski optics and fluorescent microscopy. Quantification of the different mitochondrial morphologies observed and the 
number of embryos and transgenic lines analyzed are indicated. The outlines of representative cells are indicated with dashed circles. Videos 1–4 show 
3D reconstructions of the embryos marked with asterisks.JCB • VOLUME 186 • NUMBER 4 • 2009   528
Figure 2.  CED-9 promotes mitochondrial fusion, whereas FZO-1 promotes mitochondrial aggregation in body wall muscle cells. (A) Schematic of the mito-
chondrial morphologies observed in body wall muscle cells. (B) Transgenic lines expressing mitogfp alone (Pmyo-3 mitogfp), in the presence of ced-9(wt) 
(Pmyo-3 mitogfp + Pmyo-3 ced-9(wt) (3UTRsmg)), or in the presence of fzo-1 (Pmyo-3 mitogfp + Pmyo-3 fzo-1 (3UTRsmg)) were grown at 25°C to allow the expres-
sion of the smg-inducible transgene, as indicated in Materials and methods. These lines, as well as drp-1(RNAi) animals and lea-1(RNAi) animals 
(control(RNAi)) carrying a Pmyo-3 mitogfp transgene, were analyzed by fluorescent microscopy. Quantification of the different mitochondrial morphologies 
observed and the number of body wall muscle cells and transgenic lines analyzed are indicated. nuc, nucleus; arrows, fused mitochondria; arrowheads, 
aggregated mitochondria. Error bars indicate standard deviations.529 ROLE OF CED-9/BCL-2 IN MITOCHONDRIAL FUSION • Rolland et al.
function mutations and expressing mitogfp have fragmented 
mitochondria (100%, n = 7, two independent lines; Fig. 1 B, 
rows 3 and 5).
We found that ced-9(wt) overexpression failed to promote 
mitochondrial fusion in fzo-1(tm1133) animals (0%, n = 9, three 
independent lines; Fig. 1 B, row 4). Instead, in these animals, 
mitochondria aggregated into one or two large clusters per cell, 
which is reminiscent of the phenotype caused by fzo-1 expres-
sion (Table S1 and Videos 3 and 8). We confirmed that the in-
ability of ced-9(wt) expression to promote mitochondrial fusion 
in fzo-1(tm1133) embryos was not the result of lower levels of 
CED-9 protein (Fig. S2 A). Interestingly, we found that the level 
of bc1 protein (a protein of complex III of the electron transport 
chain) is reduced in fzo-1(tm1133) animals (Fig. S2 A). This   
result is consistent with the observation that fzo-1(tm1133)   
by hyper fusion of the OMM. In summary, these results sug-
gest that, as in cultured mammalian cells, the CED-9 protein 
can promote mitochondrial fusion in C. elegans.
CED-9–induced mitochondrial fusion is 
dependent on FZO-1 and EAT-3
The dynamin-related GTPases FZO-1 and EAT-3 are required 
for mitochondrial fusion in C. elegans (Breckenridge et al., 
2008; Ichishita et al., 2008; Kanazawa et al., 2008; Tan et al., 
2008). To investigate whether the ability of the CED-9 protein 
to promote mitochondrial fusion is dependent on a functional 
fzo-1 or eat-3 gene, we analyzed transgenic animals carrying 
loss of function mutations in the fzo-1 gene (fzo-1(tm1133)) 
or the eat-3 gene (eat-3(ad426)). Consistent with previous 
studies,  transgenic  animals  homozygous  for  these  loss  of 
Figure  3.  EM  analysis  of  CED-9–induced 
mitochondrial fusion and FZO-1–induced mi-
tochondrial aggregation. (A) Transgenic lines 
expressing mitogfp alone (Pmyo-3 mitogfp) show 
wild-type muscle mitochondria lying just below 
the sarcomere. Note its abundant internal cris-
tae. (B–D) Transgenic lines expressing mitogfp 
in the presence of ced-9(wt) (Pmyo-3 mitogfp + 
Pmyo-3  ced-9(wt)  (3UTRsmg))  show  mitochon-
dria with abundant cristae. Three typical struc-
tures  were  observed.  (B)  Mitochondria  form 
elongated and branched structures. These giant 
mitochondria seem fused. Nearby tubes may 
be part of these giant mitochondria; however, 
in one thin section, it is not possible to know 
for sure. (C) Mitochondria have smaller diam-
eter and are closely clustered. In some cases, 
neighboring mitochondria may be physically 
attached to one another through the OMM. 
(D)  Mitochondria  lie  closely  together,  and 
some show nested profiles in which one tube 
is completely enveloped by another. Cristae in 
some cases run circumferentially inside narrow   
outer tubes. (E) Transgenic lines expressing mi-
togfp in the presence of fzo-1 (Pmyo-3 mitogfp +   
Pmyo-3  fzo-1  (3UTRsmg))  show  mitochondria 
with abundant cristae, which are closely clus-
tered and tend to have smaller diameters. In 
many  cases,  neighboring  mitochondria  may 
be physically attached to one another through 
the OMM. Insets show a magnified view of the 
indicated area. Bars, 500 nm.JCB • VOLUME 186 • NUMBER 4 • 2009   530
Figure 4.  The loss of ced-9 function does not cause detectable defects in mitochondrial morphology in embryos. (A) Schematic of the mitochondrial 
morphologies observed in embryos. (B) Mitochondria of wild-type (+/+), ced-3(n2427), ced-9(n2812); ced-3(n2427), ced-4(n1162), ced-9(n2812);   
ced-4(n1162), ced-9(n1653ts), ced-9(RNAi), and ced-9(n1950gf) embryos were stained using TMRE, as indicated in Materials and methods. Quantifica-
tion of the different mitochondrial morphologies observed and the number of embryos analyzed are indicated. Videos 6 and 7 show 3D reconstructions of 
wild-type and ced-9(n1653ts) embryos marked with asterisks.531 ROLE OF CED-9/BCL-2 IN MITOCHONDRIAL FUSION • Rolland et al.
animals seem to have less active mitochondria when stained 
with TMRE (unpublished data).
Similarly, we found that ced-9(wt) expression failed to 
promote mitochondrial fusion in eat-3(ad426) animals (0%, n = 8, 
two independent lines; Fig. 1 B, row 6; Table S1; and Video 4). 
Instead, like in fzo-1(tm1133) animals, ced-9(wt) expression in 
eat-3(ad426)  mutants  induced  mitochondrial  aggregation. 
Again, the inability of ced-9(wt) expression to promote mito-
chondrial fusion in eat-3(ad426) embryos was not because of 
lower levels of CED-9 protein (Fig. S2 B).
We  also  observed  that  CED-9(n1950gf)–induced  mito-
chondrial fusion was blocked by fzo-1(tm1133) and eat-3(ad426) 
(Fig. S1). Once again, the inability of ced-9(n1950gf) expres-
sion to promote mitochondrial fusion in the eat-3(ad426) or   
fzo-1(tm1133) mutant background was not because of lower 
levels of CED-9(n1950gf) protein (Fig. S2, D and E). Based on 
these results, we conclude that the CED-9 protein can promote 
mitochondrial fusion in a manner that is dependent on the dynamin-
related GTPases FZO-1 and EAT-3.
ced-9(wt) expression might have a weak 
effect on mitochondrial mass in C. elegans
Overexpression of BCL-xL has been shown to increase mitochon-
drial mass in cultured mammalian cells 3–10-fold (Berman et al., 
2009). Therefore, we investigated whether ced-9(wt) overexpres-
sion has the same effect in C. elegans. To that end, we measured 
the levels of three mitochondrial proteins by Western analysis: 
the bc1 protein, cytochrome oxidase I, and the  subunit of ATP 
synthase (these proteins are part of complexes III, IV, and V of 
the electron transport chain, respectively). No significant differ-
ences in the levels of these proteins were observed in transgenic 
lines overexpressing mitogfp and ced-9(wt) when compared with 
transgenic lines overexpressing mitogfp alone (Fig. S2 F). How-
ever, analysis of EM pictures revealed that the mitochondrial 
area is increased by 25% in transgenic lines overexpressing 
ced-9(wt) compared with control transgenic lines (Fig. S2 G). 
Therefore, we conclude that CED-9 might affect mitochondrial 
mass in C. elegans but to a much lesser extent than what has been 
observed for BCL-xL in mammalian cells.
ced-9 mutants do not display obvious 
defects in mitochondrial morphology
Based on MitoTracker staining, it has been reported that em-
bryos homozygous for a temperature-sensitive partial loss of 
function mutation of ced-9, n1653ts, have fragmented mito-
chondria (Delivani et al., 2006). Based on this observation, it 
was proposed that ced-9 plays an important role in mitochon-
drial fusion. However, we found that in contrast to TMRE,   
MitoTracker does not label mitochondria in C. elegans embryos 
(Fig. S3). For this reason, we reexamined mitochondrial mor-
phology in ced-9 mutants using TMRE. We were unable to   
detect a defect in mitochondrial morphology in ced-9(n1653ts) 
embryos at the nonpermissive temperature (100%, n = 7; Fig. 4 B, 
row 2). Furthermore, we failed to detect a defect in embryos 
homozygous for n2812, a null allele of the ced-9 gene (100%,   
n = 10; Fig. 4 B, rows 4 and 6). However, we cannot exclude 
that, in the strains analyzed, potential effects of ced-9 mutations 
on mitochondrial morphology are suppressed by the presence 
of secondary mutations. The occurrence of such compensa-
tory, secondary mutations has previously been demonstrated in   
S. cerevisiae (Cheng et al., 2008). Therefore, to rule out the   
possibility that secondary mutations mask a mitochondrial phe-
notype in ced-9 mutants, we transiently inactivated the ced-9  
gene by RNAi, which results in reduced CED-9 protein levels   
(Fig. S2 I). However, we failed to detect any mitochondrial morphol-
ogy defects after ced-9 RNAi treatment (100%, n = 10; Fig. 4 B,   
row 7). We confirmed these results using 3D reconstruction of   
z stacks of wild-type and ced-9(n1653ts) embryos (Table S1 and 
Videos 6 and 7). Finally, we also found that the mitochondrial 
morphology in ced-9(n1950gf) embryos was indistinguishable 
from the morphology observed in wild-type embryos (100%,   
n = 10; Fig. 4 B, row 8).
To elucidate whether the CED-9 protein plays a role in 
mitochondrial fusion during later stages of development, we 
analyzed mitochondrial morphology in body wall muscle cells 
of L4 larvae. Animals homozygous for ced-9(n2812) do not 
display  a  significant  fragmented  mitochondrial  morphology   
(+/+: 14%, n = 133; ced-3(n2427): 9%, n = 151; ced-9(n2812); 
ced-3(n2427): 14%, n = 109; Fig. 5). This result is consis-
tent with previous experiments (Tan et al., 2008). In addition, 
we found that ced-9(RNAi) animals do not have a significant 
fragmented mitochondrial phenotype compared with control 
RNAi animals (control(RNAi): 12%, n = 42; ced-9(RNAi): 9%, 
n = 38). In contrast, we confirmed that, as previously shown 
(Ichishita et al., 2008), fzo-1(RNAi) animals have mainly frag-
mented mitochondria (66%, n = 24; Fig. 5). Western analysis 
confirmed that CED-9 and FZO-1 protein levels were reduced 
after ced-9 and fzo-1 RNAi treatment, respectively (Fig. S2 I). 
Using  morphometric  analysis,  we  found  that  ced-9(n2812); 
ced-3(n2427)  animals  have  slightly  shorter  mitochondria 
compared with ced-3(n2427) animals (ced-3(n2427): 4.2 ± 
1.6 µm, n = 21; ced-9(n2812); ced-3(n2427): 3.5 ± 1.3 µm,   
n = 38; Fig. S4). Similarly, ced-9(RNAi) animals have slightly 
smaller mitochondria compared with control(RNAi) animals. 
(control(RNAi):  4.5  ±  1.7  µm,  n  =  11;  ced-9(RNAi):  4.3  ±   
1.4 µm, n = 24; Fig. S4). Finally, ced-9(n1950gf) animals have 
slightly longer mitochondria compared with wild-type animals 
(+/+: 3.6 ± 1.1 µm, n = 25; ced-9(n1950gf): 4.2 ± 1.5 µm, n = 
24; Fig. S4). However, in all three cases, the differences were 
not statistically significant (Fig. S4).
In summary, we conclude that, at least under normal 
growth conditions and in the absence of internal or external 
stress, ced-9 mutants do not display obvious defects in mito-
chondrial morphology during embryogenesis or in body wall 
muscle cells during larval development. However, we cannot 
rule out the idea that ced-9 mutants exhibit defects in the rate of 
mitochondrial fusion, which might not necessarily cause signif-
icant changes in mitochondrial morphology.
The loss of ced-9 function partially 
suppresses embryonic lethality  
caused by drp-1 RNAi
Animals treated with drp-1 RNAi have highly elongated and 
connected mitochondria (Labrousse et al., 1999). We tested JCB • VOLUME 186 • NUMBER 4 • 2009   532
Figure 5.  The loss of ced-9 function does not cause detectable defects in mitochondrial morphology in body wall muscle cells. (A) Schematic of the mito-
chondrial morphologies observed in body wall muscle cells. (B) Wild-type (+/+), ced-3(n2427), ced-9(n2812); ced-3(n2427), ced-9(RNAi), fzo-1(RNAi), 
and ced-9(n1950gf) L4 larvae carrying a Pmyo-3 mitogfp transgene were analyzed by fluorescent microscopy. Quantification of the different mitochondrial 
morphologies observed and the number of body wall muscle cells and transgenic lines analyzed are indicated, and quantification of the mitochondrial 
length is shown in Fig. S4. nuc, nucleus. Error bars indicate standard deviations.533 ROLE OF CED-9/BCL-2 IN MITOCHONDRIAL FUSION • Rolland et al.
whether  drp-1  RNAi–induced  changes  in  mitochondrial 
morphology are dependent on the presence of a functional   
ced-9  gene.  To  that  end,  we  analyzed  the  effect  of  drp-1 
RNAi  on  mitochondrial  morphology  in  wild-type  animals 
and ced-9(n2812) animals. In both cases, we observed highly 
elongated  and  connected  mitochondria  (unpublished  data). 
However, although drp-1 RNAi induced 26% (± 6.2%, n = 
309) of embryonic lethality on average in a wild-type back-
ground, it only induced 16% (± 2.8%, n = 278) of embryonic 
lethality on average in a ced-9(n2812) background. Interest-
ingly, like the complete inactivation of drp-1 by RNAi in the 
ced-9(n2812) background, the partial inactivation of drp-1 by 
RNAi in a wild-type background also caused highly elongated 
and connected mitochondria and 9.8% (± 4.1%, n = 117) em-
bryonic lethality on average. Thus, an effect on the rates of 
mitochondrial fusion and fission that does not cause detectable 
changes in steady-state mitochondrial morphology can cause a 
detectable increase in embryonic survival. Therefore, it is pos-
sible that the suppression of drp-1 RNAi–induced embryonic 
lethality by the loss of ced-9 function is caused by a reduction 
in the rate of mitochondrial fusion.
The CED-9 protein physically interacts with 
the FZO-1 protein
To determine whether CED-9 can physically interact with   
FZO-1 or EAT-3, we used the yeast two-hybrid system. We found 
that CED-9 can interact with FZO-1 (Fig. 6 A). We confirmed 
the interaction in vitro using GST pull-down experiments.   
Specifically, in vitro–translated, [
35S]methionine-labeled FZO-1 
protein copurified with GST-tagged CED-9 (GST::CED-9) pro-
tein but not with GST alone. In vitro–translated, [
35S]methionine- 
labeled control proteins (luciferase or the yeast protein SSN6p) 
did not copurify with GST::CED-9, indicating that the interac-
tion between GST::CED-9 and FZO-1 is specific (Fig. 6 B). 
Similarly, in vitro–translated, [
35S]methionine-labeled CED-9 
copurified with GST-tagged FZO-1 (GST::FZO-1) protein but 
not with GST alone (Fig. 6 C). To validate the interaction in 
vivo, using an anti-GFP antibody, we immunoprecipitated func-
tional FZO-1::GFP fusion protein or a control GFP fusion pro-
tein  (GFP::TRA-4)  from  lysates  generated  from  transgenic 
animals expressing fzo-1::gfp or gfp::tra-4 under the control of 
an  inducible  promoter  (PHSfzo-1::gfp)  or  the  tra-4  promoter 
(Ptra-4gfp::tra-4). Using a CED-9–specific antibody (Fig. S2 H), 
we found that endogenous CED-9 coimmunoprecipitated with 
FZO-1::GFP but not GFP::TRA-4 (Fig. 6 D). Furthermore,   
endogenous  CED-9  was  not  detected  in  precipitates  from   
nontransgenic animals, and the anti-GFP antibody failed to 
coimmunoprecipitate an unrelated protein, NHL-2 (Hammell   
et al., 2009). Therefore, CED-9 can physically interact with 
FZO-1 in vivo, and this interaction is most probably direct.
To identify the domains of FZO-1 required for binding to 
CED-9, we tested fragments of the FZO-1 protein for their abil-
ity to bind to CED-9 in vitro. We found that FZO-1 binds to 
CED-9 predominantly through its central domain (aa 346–595), 
which is predicted to form a coiled-coil structure (Fig. 6 E). In 
addition, we found that FZO-1 can also bind to CED-9 through 
its  N-terminal  part  (aa  1–219),  which  contains  the  GTPase   
domain and is predicted to form a coiled-coil structure (Fig. 6 E). 
We did not observe a significant interaction between aa 1–375 
of the FZO-1 protein and CED-9, suggesting that aa 219–375 
might form a domain that antagonizes the interaction between 
FZO-1 and CED-9. The presence of an inhibitory domain at aa 
220–345 would also explain why aa 346–595 of the FZO-1 pro-
tein  have  a  stronger  affinity  for  CED-9  than  the  full-length 
FZO-1 protein (Fig. 6 E).
We also found that CED-9 interacts with EAT-3 in vitro 
and that this interaction is dependent on the N-terminal domain 
of the EAT-3 protein, which is predicted to form a coiled-coil 
structure (Fig. S5, A and B). However, we were not able to re-
producibly confirm this interaction in vivo, indicating that this 
interaction might be very weak or transient.
CED-9(R211E, N212G) has reduced 
affinity for FZO-1
Two mutant CED-9 proteins, CED-9(N158A, A159G, Q160A) 
and CED-9(R211E, N212G), have been shown to have reduced 
affinity for the C. elegans CED-4 protein, a known interactor of 
CED-9 in healthy cells (Yan et al., 2004). We confirmed this   
using GST pull-down experiments (unpublished data). We then 
tested  CED-9(N158A, A159G,  Q160A)  and  CED-9(R211E, 
N212G) for their ability to bind to FZO-1 in vitro. We found that 
compared with wild-type CED-9 protein, the affinity of CED-
9(R211E, N212G) for FZO-1 was three times lower. In contrast, 
the affinity of CED-9(N158A, A159G, Q160A) for FZO-1 was 
not significantly reduced (Fig. 6 F). aa 211 and 212 are located 
at the N terminus of the BH2 domain of CED-9. Therefore, the 
BH2 domain might play an important role in the interaction be-
tween CED-9 and FZO-1. Similarly, CED-9(R211E, N212G) 
but not CED-9(N158A, A159G, Q160A) has reduced affinity 
for EAT-3 in vitro (Fig. S5 C).
CED-9–induced mitochondrial fusion is 
dependent on the ability of CED-9 to 
interact with FZO-1
Because  CED-9(R211E,  N212G)  has  reduced  affinity  for 
FZO-1, we tested whether these mutations affect CED-9’s 
ability to promote mitochondrial fusion. We used the protein 
CED-9(N158A, A159G, Q160A) as control protein because 
it has wild-type affinity with respect to FZO-1 binding but, 
like CED-9(R211E, N212G), reduced affinity with respect to   
CED-4 binding. We generated transgenic animals expressing 
mitogfp  and  either  ced-9(N158A, A159G,  Q160A)  or  ced-9 
(R211E, N212G) and analyzed mitochondrial morphology in 
transgenic embryos. We found that, like ced-9(wt) expression, 
the expression of ced-9(N158A, A159G, Q160A) caused the 
formation of one or two large, highly globular mitochondria 
per cell (100%, n = 10, three independent lines; Fig. 7 B, top). 
In contrast, ced-9(R211E, N212G) expression promoted mito-
chondrial fusion less efficiently. Specifically, it caused the for-
mation of two to four smaller, globular mitochondria per cell 
(100%, n = 10, three independent lines; Fig. 7 B, bottom). The 
difference in mitochondrial fusion caused by ced-9(N158A, 
A159G, Q160A) or ced-9(R211E, N212G) expression was not 
caused by a difference in CED-9 protein level (Fig. S2 C). JCB • VOLUME 186 • NUMBER 4 • 2009   534
Figure 6.  CED-9 physically interacts with FZO-1. (A) CED-9 interacts with FZO-1 in yeast. BD, Gal4p-binding domain; AD, Gal4p activation domain.   
(B and C) CED-9 interacts with FZO-1 in vitro. GST::CED-9 and GST::FZO-1 were used in pull-down experiments in the presence of in vitro–translated   
[
35S]-labeled FZO-1 and CED-9, as described in Materials and methods. (D) CED-9 and FZO-1 interact in vivo. Embryonic lysates from wild-type (N2) an-
imals or animals expressing PHS-fzo-1::gfp or Ptra-4-gfp::tra-4 were immunoprecipitated using anti-GFP antibodies, as described in Materials and methods. 
The precipitated proteins (IP) were analyzed for the presence of endogenous CED-9 or NHL-2 protein. (E) CED-9 interacts with the central domain of FZO-1 535 ROLE OF CED-9/BCL-2 IN MITOCHONDRIAL FUSION • Rolland et al.
predicted to form a coiled-coil structure. The percentage of truncated FZO-1 protein pulled down was normalized to the percentage of full-length FZO-1 
protein pulled down (n = 2). CC, coiled-coil regions; TM, transmembrane domain. (F) Mutations in the BH2 domain of CED-9 affect its ability to interact 
with FZO-1. The percentage of FZO-1 pulled down by the GST::CED-9 mutant was normalized to the percentage of FZO-1 pulled down by GST::CED-9(wt) 
(n = 6) . *, P < 0.0001 by Student’s t test. Error bars indicate standard deviations.
 
Therefore, we conclude that the ability of CED-9 to induce 
mitochondrial fusion is dependent on its ability to interact 
with FZO-1 but not CED-4.
The expression of fzo-1 and eat-3 is not 
sufficient to cause mitochondrial fusion
To determine whether fzo-1 or eat-3 expression causes exces-
sive mitochondrial fusion as observed in animals expressing 
ced-9(wt), we generated transgenic animals expressing mitogfp 
with fzo-1, eat-3, or fzo-1 and eat-3 and analyzed mitochondrial 
morphology in transgenic embryos. Unlike ced-9(wt) expres-
sion, the expression of fzo-1 caused the tubular mitochondria 
to aggregate into one or two large clusters per cell (100%, n = 7, 
two independent lines; Fig. 8 B, row 1; Table S1; and Video 8). 
This result was confirmed in body wall muscle cells. Although   
ced-9(wt) overexpression caused a complete mitochondrial   
fusion  (Figs.  2  and  3),  fzo-1  overexpression  caused  only   
mitochondrial aggregation (Figs. 2 and 3). Surprisingly, the 
expression of eat-3 caused mitochondria to fragment (100%, 
n = 12, three independent lines; Fig. 8 B, row 2; Table S1; and 
Video 9). Furthermore, like the expression of fzo-1 alone, the 
expression of both fzo-1 and eat-3 caused mitochondria to ag-
gregate into one or two large clusters per cell (85%, n = 7, two 
independent lines; Fig. 8 B, row 3; Table S1; and Video 10). 
Finally, the expression of both fzo-1 and eat-3 in the absence 
of a functional drp-1 gene (i.e., in the drp-1(tm1108) back-
ground) caused many of the transgenic animals to be nonvi-
able (unpublished data). The few embryos that we were able 
to analyze exhibited a highly elongated and connected mito-
chondrial morphology similar to the morphology observed in   
drp-1(tm1108) embryos expressing mitogfp alone (100%, n = 5, 
one independent line; Fig. 8 B, row 5).
In summary, we conclude that overexpression of the mito-
chondrial fusion machinery is not sufficient to cause mitochon-
drial fusion in either a wild-type or drp-1–deficient background. 
However, we cannot completely rule out the possibility that the 
lethality  induced  by  the  expression  of  fzo-1  and  eat-3  in  the   
drp-1(tm1108) background masks a potential fusion phenotype.
Discussion
ced-9(wt) expression in C. elegans is 
sufficient to induce FZO-1– and EAT-3–
dependent mitochondrial fusion
Members of the family of BCL-2–like proteins have recently 
been implicated in the regulation of mitochondrial fusion (Cerveny 
et al., 2007). For example, the BCL-2–like proteins Bax and 
Bak have been shown to be required for mitochondrial fusion in 
Figure 7.  CED-9(R211E, N212G) is less effective in the promotion of mitochondrial fusion. (A) Schematic of the mitochondrial morphologies observed 
in embryos. (B) Transgenic lines overexpressing mitogfp in combination with ced-9(N158A, A159G, Q160A) (PHSmitogfp + PHSced-9(N158A, A159G, 
Q160A)) or ced-9(R211E, N212G) (PHSmitogfp + PHSced-9(R211E, N212G)) were analyzed by Nomarski optics and fluorescent microscopy. The outline 
of cells is indicated in the schematic of the mitochondrial network. Quantification of the different mitochondrial morphologies observed and the number of 
embryos and transgenic lines analyzed are indicated.JCB • VOLUME 186 • NUMBER 4 • 2009   536
fusion in C. elegans embryos. In addition, we show that CED-9–
induced mitochondrial fusion generates giant mitochondria, 
which in general have normal OMM, IMM, and cristae struc-
ture. Therefore, CED-9 can promote the complete fusion of the 
OMM and IMM. Furthermore, we demonstrate that CED-9’s 
ability to promote mitochondrial fusion is dependent on the 
genes fzo-1 and eat-3. Specifically, ced-9(wt) expression in em-
bryos carrying loss of function mutations in the fzo-1 or eat-3 
mammals (Karbowski et al., 2006). Furthermore, the C. elegans 
BCL-2–like protein CED-9 has been shown to promote mito-
chondrial fusion when expressed in cultured mammalian cells 
(Delivani et al., 2006). Recently, CED-9 has also been shown to 
promote mitochondrial fusion in C. elegans body wall muscle 
cells (Tan et al., 2008). In this study, we confirm that CED-9 can 
promote mitochondrial fusion in C. elegans body wall muscle 
cells, and we demonstrated that it can also promote mitochondrial 
Figure 8.  Expression of fzo-1 and eat-3 does not promote complete mitochondrial fusion. (A) Schematic of the mitochondrial morphologies observed in 
embryos. (B) Wild-type (+/+) or drp-1(tm1108) transgenic lines expressing mitogfp in the presence of fzo-1 (PHSmitogfp + PHSfzo-1), eat-3 (PHSmitogfp + 
PHSeat-3), or both fzo-1 and eat-3 (PHSmitogfp + PHSfzo-1 + PHSeat-3) were analyzed by Nomarski optics and fluorescent microscopy. Quantification of the 
different mitochondrial morphologies observed and the number of embryos and transgenic lines analyzed are indicated. The outlines of representative cells 
are indicated with dashed circles. Videos 8–10 show 3D reconstructions of the embryos indicated by asterisks.537 ROLE OF CED-9/BCL-2 IN MITOCHONDRIAL FUSION • Rolland et al.
of EAT-3 through a mechanism that remains to be elucidated. 
Alternatively, CED-9 might insert into the OMM and interact 
with EAT-3 in the intermembrane space to directly promote 
tethering and/or IMM fusion.
The role of CED-9 in mitochondrial fusion
Our results show that CED-9 can promote complete mitochon-
drial fusion in C. elegans by interacting with the mitochondrial 
fusion machinery. These results are consistent with previous 
work by Delivani et al. (2006) in cultured mammalian cells and 
by Tan et al. (2008) in C. elegans. However, our results are in 
apparent  contradiction  with  recent  work  from  Breckenridge   
et al. (2009), who proposed that CED-9 plays no role in mito-
chondrial dynamics in C. elegans. The discrepancy between 
their results and our results can possibly be explained by   
the higher concentration of the PHSced-9(wt) transgene used   
by  Breckenridge  et  al.  (2009)  to  generate  transgenic  lines   
(25 ng/µl instead of 5 ng/µl in our study). Based on our analy-
ses of body wall muscle cells, the resulting high levels of CED-
9 protein might be toxic and therefore cause transgenic animals 
to be nonviable. Breckenridge et al. (2009) selected for trans-
genic animals that carry stable, integrated transgenes in their 
genomes.  During  this  process,  CED-9–dependent  toxicity 
might have led to the selection of lines generating very low 
levels of CED-9 protein from the ced-9(wt) transgene. This 
low level of CED-9 might be sufficient to block apoptosis but 
not to promote mitochondrial fusion. Because Breckenridge   
et al. (2009) did not analyze CED-9 protein levels in their trans-
genic lines, it remains to be determined how their results relate 
to the results presented in this study.
Our results also indicate that, unlike FZO-1 and EAT-3, 
CED-9 does not play a major role in mitochondrial fusion dur-
ing embryogenesis or in body wall muscle cells during larval 
development. Indeed, even though ced-9 loss of function ani-
mals  have  slightly  shorter  mitochondria  and  ced-9(n1950gf) 
animals have slightly longer mitochondria when compared with 
control animals, the differences are not statistically significant. 
Similarly,  we  found  that  ced-9(n2812)  can  suppress  drp-1 
RNAi–induced embryonic lethality, possibly by reducing the 
rate of mitochondrial fusion. However, we could not detect an 
effect of ced-9(n2812) on the mitochondrial morphology phe-
notype caused by drp-1 RNAi.
If ced-9 does not have a major role in mitochondria fu-
sion, what could its physiological role be? We are considering 
the following four possibilities: (1) the role of ced-9 in mito-
chondrial fusion might be redundant with that of one or more 
additional genes. Thus, the inactivation of ced-9 alone might 
not  be  sufficient  to  cause  a  defect  in  mitochondrial  fusion.   
(2) ced-9 might play a minor role in mitochondrial fusion dur-
ing embryogenesis and in body wall muscle cells during larval 
development. In that case, the loss of ced-9 function might not 
cause a detectable phenotype when analyzing steady-state mito-
chondrial morphology. (3) ced-9 has previously been shown to 
promote mitochondrial fission during apoptosis (Jagasia et al., 
2005). Therefore, ced-9 has both profusion and profission activ-
ities.  As  a  consequence,  the  loss  of  ced-9  function  might   
affect both fusion and fission rates, resulting in no net change in 
gene failed to cause complete mitochondrial fusion and, instead, 
caused mitochondrial aggregation.
In contrast, fzo-1, eat-3, or fzo-1 and eat-3 overexpression 
did not result in the generation of giant mitochondria and there-
fore presumably did not cause complete fusion of the OMM and 
IMM.  Instead,  fzo-1  overexpression  promoted  mitochondrial 
aggregation, which is reminiscent of the phenotype caused by 
Mfn1,2 expression in cultured mammalian cells (Santel et al., 
2003). It has been proposed that by promoting the tethering of 
mitochondria and the fusion of the OMM, Mfn1,2 acts at an 
early step during mitochondrial fusion (Koshiba et al., 2004). 
Although CED-9 promotes a complete fusion of both mem-
branes, FZO-1 might therefore only cause hyper tethering and/
or fusion of the OMM. Surprisingly, both the loss of eat-3 func-
tion and eat-3 overexpression caused mitochondrial fragmenta-
tion. Thus, EAT-3 might have dual roles in fusion and fission in 
C. elegans, as it has been proposed for Opa1 in mammalian cells 
(Cipolat et al., 2004; Griparic et al., 2004). The mechanism 
through which Opa1 overexpression causes fission remains elu-
sive. However, it does not seem to be caused by a block in fusion 
but by Drp1-dependent fission (Chen et al., 2005).
The CED-9 protein promotes mitochondrial 
fusion by directly interacting with FZO-1
We demonstrate that CED-9 can interact with FZO-1 in yeast, 
in vitro, and in vivo. In addition, mutations that affect the BH2 
domain of CED-9 reduce the affinity of CED-9 for FZO-1. The 
analysis of the CED-9(R211E, N212G) mutant revealed that the 
ability of CED-9 to promote mitochondrial fusion is not only 
dependent on the presence of a functional FZO-1 protein but on 
the ability of CED-9 to physically interact with it. Furthermore, 
the identification of the domains of FZO-1 required for the in-
teraction of FZO-1 with CED-9 revealed a domain predicted   
to form a coiled-coil structure. The function of this domain ap-
pears to be evolutionary conserved because Bax and Bak have 
been shown to interact with Mfn2, and the corresponding do-
main of Mfn2 has been shown to be required for this interaction 
(Karbowski et al., 2006; Brooks et al., 2007). The identification 
of a physical interaction between CED-9 and FZO-1 supports 
the notion that CED-9 plays a role in mitochondrial fusion. 
However, several questions remain to be addressed. For exam-
ple, it is currently unclear how CED-9 regulates the activity of 
FZO-1. Recent studies have shown that CED-9 in C. elegans 
and BCL-xL in mammals can enhance the GTPase activity of 
the fission protein DRP-1/Drp1 (Li et al., 2008; Tan et al., 2008). 
Therefore, it is possible that CED-9 regulates FZO-1 function 
and promotes mitochondrial fusion by enhancing the GTPase 
activity of FZO-1. Alternatively, CED-9 could affect the ability 
of FZO-1 to dimerize. We found that CED-9 can also interact 
with EAT-3 in vitro. However, we were not able to reproducibly 
observe this interaction in vivo, which suggests that it might be 
very weak or transient.
Based on our results, we speculate that CED-9–induced 
mitochondrial fusion proceeds through the following sequential 
steps: (1) CED-9 interacts with FZO-1 to promote mitochon-
drial tethering and/or OMM fusion, and (2) CED-9–dependent 
activation of FZO-1 results in the FZO-1–dependent activation JCB • VOLUME 186 • NUMBER 4 • 2009   538
RNA-mediated interference
RNAi was performed as described previously (Timmons et al., 2001). For 
ced-9 RNAi, rrf-3(pk1426) L4 larvae were grown at 15°C on ced-9 RNAi 
plates for 24 h and transferred for 16 h onto regular TMRE plates without 
RNAi. Adults were cut open, and embryos were mounted in M9 medium 
and analyzed by Nomarski optics and fluorescent microscopy.
Partial inactivation of drp-1 by RNAi was achieved by mixing the 
Escherichia coli strain producing drp-1 dsRNA with an E. coli strain carry-
ing a mock RNAi plasmid.
Analysis of mitochondrial morphology in body wall muscle cells
Adult Rol animals (transgenic animals) were allowed to lay eggs for 2 h at 
20°C and were then removed. Plates were incubated for 2–3 d at 20°C, 
and Rol L4 larvae of the next (F1) generation were analyzed by Nomarski 
optics and fluorescent microscopy. For RNAi experiments, Rol L4 larvae 
were grown on RNAi plates for 24 h at 20°C and transferred to fresh RNAi 
plates for 2–3 d. Rol L4 larvae of the F1 generation were analyzed by   
Nomarski optics and fluorescent microscopy. Muscle cells with >50% of 
fragmented mitochondria were scored as muscle cells with a mitochondrial 
fragmentation phenotype. Scoring was performed blind.
Overexpression experiments
L4 larvae from transgenic lines were picked and grown at 20°C for 24 h. 
Nonmultivulval adults (transgenic animals) were transferred to new plates, 
allowed to lay eggs for 2 h at 20°C, heat shocked at 32°C for 45 min, and 
incubated at 20°C for 1 h and 15 min before being removed from the 
plates. Eggs laid during the 4-h period were mounted in M9 medium and 
analyzed by Nomarski optics and fluorescent microscopy. Throughout this 
study, transgenic animals carrying extrachromosomal arrays were used. 
Those animals are mosaic for the presence of the transgenes and thus the 
expression of the transgenes. However, the mitochondrial morphology ob-
served in individual mitoGFP-positive cells in a given embryo was in gen-
eral  homogeneous.  For  this  reason,  the  data  are  presented  as  the 
percentage of embryos showing a certain phenotype.
Pmyo-3 smg–inducible system
This system takes advantage of a temperature-sensitive allele of a compo-
nent of the Smg RNA surveillance machinery (smg-1(cc546ts)). In a smg-
1(cc546ts) mutant background, an mRNA with an abnormally long 3 UTR 
(3UTRsmg) is degraded at the permissive temperature (15°C) but trans-
lated at the nonpermissive temperature (25°C). Full-length ced-9 and fzo-1 
cDNAs were cloned into pPD118.60 (provided by A. Fire, Stanford School 
of Medicine, Stanford, CA) to construct Pmyo-3 ced-9(wt) (3UTRsmg) and 
Pmyo-3 fzo-1 (3UTRsmg). smg-1(cc546ts) transgenic animals carrying Pmyo-3 
ced-9(wt) (3UTRsmg) or Pmyo-3 fzo-1(3UTRsmg) were maintained at 15°C 
and transferred at 25°C to induce the expression of the transgene. L4 lar-
vae of the F1 generation were analyzed by fluorescent microscopy or 
transmission EM.
Image acquisition and processing
Imaging was performed at 20°C using a microscope equipped with a 
100× 1.3 NA oil lens (Axioskop 2; Carl Zeiss, Inc.) and a charge-coupled 
device camera (1300; Micromax). A Nomarski and fluorescent z stack of 
each embryo (0.5 µm/slice) was acquired using MetaMorph software (ver-
sion 7.1; MDS Analytical Technologies). The same acquisition time was 
used for each experiment (10 ms for Nomarski, 100 ms for TMRE staining, 
and  200  ms  for  mitoGFP).  The  fluorescent  images  were  deconvoluted   
(10  iterations)  blind  using  AutoDeblur/AutoVisualize  software  (version 
1.4.1; Media Cybernetics). Images shown in the figures correspond to single 
planes. Images were inverted, and their contrast was enhanced using Paint 
Shop Pro X software (Corel). The resulting images were used to generate 
the schematics of the mitochondrial network. Analysis of mitochondrial 
length in body wall muscle cells was performed on deconvoluted images 
using MetaMorph.
Transmission EM
Wild-type and mutant nematodes were prepared for EM by high pressure 
freezing (HPM 010; Bal-Tec) and freeze substitution (RMC FS-7500; Boeck-
eler Instruments) into 1% osmium tetroxide in acetone (2% water added) 
following a standard protocol (Weimer, 2006) and embedded in plastic 
resin (Embed 812; Electron Microscopy Sciences). Semithin sections (0.5–
0.75 µm) were cut (MT6000; RMC) and stained with Toluidine blue to de-
termine the location within the fixed animal. When the desired area was 
located, thin sections (70–90 nm) were collected on 400 mesh 8 U thin-bar 
grids (EMS400H-Cu). Finally, the grids were stained with 2% methanolic 
steady-state mitochondrial morphology. (4) ced-9 might play a 
role in mitochondrial fusion only during certain developmental 
stages, in specific cell types, or under conditions of stress. 
Therefore, the loss of ced-9 function might cause a detectable 
phenotype only in the presence of such a specific cellular signal. 
We favor the last two possibilities. Specifically, we propose that 
in the absence of a specific cellular signal, the CED-9 protein 
promotes  both  mitochondrial  fusion  and  fission  and  that  in 
healthy cells, these opposing activities are balanced. Further-
more, we propose that in response to a specific cellular signal, 
CED-9 profusion and/or profission activity changes, which af-
fects the balance between fusion and fission and thus mitochon-
drial morphology. The goal of future studies is to further test 
this model experimentally and to fully elucidate the physiologi-
cal role of ced-9 in mitochondrial dynamics.
C. elegans CED-9 is not the only BCL-2–like protein with 
an apparent role in both mitochondrial fusion and fission. For 
example, although BCL-xL expression promotes mitochondrial 
fusion in cultured mammalian cells, it has been shown to be re-
quired for mitochondrial fragmentation in neurons (Delivani   
et al., 2006; Li et al., 2008; Berman et al., 2009). Similarly, de-
pending on the cellular context, Bax and Bak can either pro-
mote mitochondrial fusion or fission (Desagher and Martinou, 
2000; Karbowski et al., 2002, 2006; Brooks et al., 2007). There-
fore, analyzing the regulation of the opposing roles of BCL-2–
like  proteins  in  mitochondrial  dynamics  represents  another 
future challenge.
Materials and methods
General methods and strains
C. elegans strains were cultured as described previously (Brenner, 1974). 
Bristol N2 was used as the wild-type strain. Mutations used in this study are 
listed below and were described previously by Riddle et al. (1997) except 
where noted otherwise: LG I, smg-1(cc546ts) (Pulak and Anderson, 1993); 
LG II, fzo-1(tm1133) (National BioResource Project), dpy-10(e128), and 
eat-3(ad426); LG III, ced-4(n1162), ced-9(n1653ts), ced-9(n1950gf), and 
ced-9(n2812) (Hengartner and Horvitz, 1994b); LG IV, drp-1(tm1108) 
(National BioResource Project), ced-3(n717), and ced-3(n2427) (Hengartner 
and Horvitz, 1994b); and LG X, lin-15(n765ts).
Transgenic animals
For the analysis of mitochondrial morphology in embryos, all plasmids were 
injected into lin-15(n765ts) animals using 50 ng/µl pL15EK, which contains 
the lin-15–rescuing fragment, as a coinjection marker. PHSmitogfp was in-
jected at 1 ng/µl, PHSced-9(wt) (pBC876/877), PHSced-9  (N158A, A159G, 
Q160A)  (pBC636/637),  PHSced-9(R211E,  N212G)  (pBC638/639), 
PHSdrp-1 (pBC401/403), and PHSfzo-1 (pBC647/648) at 5 ng/µl, PHSeat-3  
(pBC673/674) at 20 ng/µl, and PHSfzo-1::gfp (pBC683/684) at 10 ng/µl.
For the analysis of mitochondrial morphology in body wall muscle 
cells,  all  plasmids  were  coinjected  with  pRF4,  which  contains  the  rol-
6(su1006dm) allele, which causes a dominant Rol phenotype (80 ng/µl; 
Kramer et al., 1990). Pmyo-3 mitogfp (provided by A. Van der Bliek, Univer-
sity of California, Los Angeles, Los Angeles, CA) was injected at 5 ng/µl, 
Pmyo-3  ced-9(wt)  (3UTRsmg)  (pBC862)  at  20  ng/µl,  and  Pmyo-3  fzo-1 
(3UTRsmg) (pBC863) at 20 ng/µl. For a summary of all the transgenic 
lines generated for this study, see Table S2.
Analysis of mitochondrial morphology in embryos using TMRE or 
MitoTracker staining
Adult animals were grown at 20°C in the presence of 30 µM TMRE (Invit-
rogen) for 16 h as described previously (Jagasia et al., 2005) or in the 
presence  of  0.4  µg/ml  MitoTracker-CMXRos  as  described  previously   
(Delivani et al., 2006). For ced-9(n1653ts), adults were grown at 20°C in 
the presence of TMRE for 12 h and then shifted to 25°C for 4 h.539 ROLE OF CED-9/BCL-2 IN MITOCHONDRIAL FUSION • Rolland et al.
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